beta-D-fructose

HCID 439709CAS 470-23-5

基本情報

標準SMILES
OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O
InChIKey
RFSUNEUAIZKAJO-ARQDHWQXSA-N
分子式
C6H12O6
平均分子量
180.16 g/mol
単同位体質量
180.0633881

概要

Beta-D-fructofuranose is a D-fructofuranose. It has a role as a mouse metabolite. It is an enantiomer of a beta-L-fructofuranose.

名称と識別子

優先名称
beta-D-fructose
IUPAC
(2R,3S,4S,5R)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol
英語名
(2R,3S,4S,5R)-2,5-Bis(hydroxymethyl)-oxolane-2,3,4-triol
分子式
C6H12O6
分子量
180.16

名称と別名

beta-D-fructofuranosebeta-Levulosebeta-D-Fructosebeta-Fruit sugar53188-23-1beta-D-Arabino-hexuloseB986VTP17JCHEBI:28645DTXSID60859011RefChem:937011GlyTouCan:G23778LQBETA-D.-FRUCTOFURANOSE
名称をさらに表示
Lactulose Impurity 31Lactulose Impurity 11Cyanocobalamin Impurity 13 Acetate
DTXCID103081DTXSID20273991G23778LQ470-23-5Fructooligosaccharides(2R,3S,4S,5R)-2,5-bis(hydroxymethyl)tetrahydrofuran-2,3,4-triolb-D-Fructofuranose308066-66-2

データベース識別子

CAS
470-23-5、53188-23-1、57-48-7
PubChem CID
439709
DTXSID
DTXSID60859011
ChEMBL
CHEMBL604608
ChEBI
CHEBI:28645
UNII
B986VTP17J
Nikkaji
J450.088A

物性

構造計算による物性

XLogP
-2.3
極性表面積
110 Ų
水素結合供与体数
5
水素結合受容体数
6
回転可能結合数
2
重原子数
12

実験および物理化学的性質

Solubility778 mg/mL at 20 °C
Melting Point119 - 122 °C
Physical DescriptionSolid

物理化学的性質

沸点
440.1 · 440.1±45.0 °C(Predicted)
比重(密度)
1.694 · 1.694±0.06 g/cm3(Predicted)
酸解離定数(Pka)
11.42 · 11.42±0.70(Predicted)

安全と法規制

毒性情報

Health Effects · 1 件

Acute consumption of fructose or high fructose corn syrup is essentially non-toxic. Chronic, excess fructose consumption has been shown to be a cause (or indirect cause) of gout, insulin resistance, hypertension, obesity, fatty liver disease, elevated LDL cholesterol and elevated triglycerides, leading to metabolic syndrome. In Wistar rats, a laboratory model of diabetes, 10% fructose feeding as opposed to 10% glucose feeding was found to increase blood triglyceride levels by 86%, whereas the same amount of glucose had no effect on triglycerides. A 2008 study found a substantial risk of incident gout associated with the consumption of fructose or fructose-rich foods. It is suspected that the fructose found in soft drinks (e.g., carbonated beverages) and other sweetened drinks is the primary reason for this increased incidence.

Exposure RoutesIngestion
Toxicity Summary · 1 件

Fructose is distinct from other sugars in its ability to cause intracellular ATP depletion, nucleotide turnover, and the generation of uric acid. Uric acid is generated via fructose due to its rapid phosphorylation (to fructose-1-phosphate) in the liver, leading to a rapid drop in free phosphate and ATP. This drop in ATP leads to the stimulation of adenosine monophosphate (AMP) deaminase which deaminates AMP to produce IMP, which is subsequently converted to uric acid (A15346). Uric acid is normally an anti-oxidant but without sufficient amounts of ascorbic acid (vitamin C) present in the plasma, it functions as a pro-oxidant. Because many soft drinks and foods that are sweetened with high fructose corn syrup do not contain vitamin C, the resulting uric acid can lead to a number of harmful effects, including gout, chronic inflammation, hypertension, increased adiposity, fatty liver disease and obesity (A15346). Many studies have shown that elevated uric acid levels are associated with several metabolic and cardiovascular conditions, including diabetes and coronary artery disease (A15346). Elevated serum uric acid has also been shown to be the most reliable predictor for the development of hypertension and incident renal disease (A15347) as well as fatty liver disease (A15348). Fructose-induced uric acid generation also causes mitochondrial oxidative stress that stimulates fat accumulation independent of excessive caloric intake (A15349). Several studies have demonstrated that oxidative stress is one of the earliest phenomena observed in vascular, renal, liver cells and adipocytes exposed to uric acid (A15347). High fructose consumption is also associated with more severe depletion of liver ATP, which may impair liver "energy balance”. High-fructose beverages have also been shown to lead to lower circulating insulin and leptin levels, and higher ghrelin levels. Since leptin and insulin decrease appetite and ghrelin increases appetite, some researchers suspect that eating large amounts of fructose increases the likelihood of weight gain.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity Data · 1 件

Consuming more than 100 g a day of pure fructose may lead to a modest but statistically significant rise in body weight of 0.44 kg a week. Consuming 100 g or more of fructose a day also significantly increases fasting levels of serum triglycerides. LD50: 15000 mg/kg (intravenous, rabbit)

安全データ

危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H302

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Free fructose is absorbed directly by the intestine. When fructose is consumed in the form of sucrose, it is digested (broken down) and then absorbed as free fructose. Fructose absorption occurs on the mucosal membrane via facilitated transport involving GLUT5 and GLUT2 transport proteins. Fructose is phosphorylated in the liver by fructokinase (Km= 0.5 mM). Fructokinase initially produces fructose 1-phosphate, which is split by aldolase B to produce the trioses dihydroxyacetone phosphate (DHAP) and glyceraldehyde. DHAP is then converted to glycerol-3-phophate which stimulates production of triglycerides. Nearly half (45%) of all pure fructose consumed is used up within 3-6 hours by the body for energy. If fructose is consumed with glucose (as it typically is in nature), up to 66% of it is used for energy within the same time frame. Roughly a third (29%) to a half (54%) of all fructose consumed is converted to glucose. Less than 1% of fructose appears to be directly converted to triglycerides.

Tissue LocationsLiver
Cellular LocationsExtracellular
Metabolite PathwaysAmino Sugar Metabolism

サプライヤー32 社

陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
山东泰诚生物科技有限公司18769832557 18769832557 · [email protected]
天津市光复科技发展有限公司022-85689490 13132141716 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]

関連反応

3 件

関連ノート

読み込み中…